Evidence map›Paper›PMID 28005261›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.

J Capellades, P Teixidor, G Villalba, C Hostalot, G Plans, R Armengol, S Medrano, A Estival, R Luque, S Gonzalez and 5 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

J CapelladesNeuro-radiology Service, Hospital del Mar, 08003, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0771-0390
P TeixidorNeurosurgery Service, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain.
G VillalbaNeurosurgery Service, Hospital del Mar, 08003, Barcelona, Spain.
C HostalotNeurosurgery Service, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain.
G PlansNeurosurgery Service, Hospital de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.
R ArmengolNeurosurgery Service, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain.
S MedranoNeuro-radiology Service, Hospital del Mar, 08003, Barcelona, Spain.
A EstivalMedical Oncology Service, Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, IGTP, Ctra Canyet, s/n, 08916, Badalona, Spain.
R LuqueMedical Oncology Service, Hospital Universitario Virgen de las Nieves, 18014, Granada, Spain.
S GonzalezNeuro-radiology Service, Hospital del Mar, 08003, Barcelona, Spain.
M Gil-GilMedical Oncology Service, Institut Catala d'Oncologia, Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
S VillaRadiation Oncology Service, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain.
J SepulvedaMedical Oncology Service, Hospital Universitario 12 de Octubre, 28041, Madrid, Spain.
J J García-MosqueraMedical Oncology Service, Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, IGTP, Ctra Canyet, s/n, 08916, Badalona, Spain.
C BalanaMedical Oncology Service, Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, IGTP, Ctra Canyet, s/n, 08916, Badalona, Spain. cbalana@iconcologia.net.
Hospital Del Mar · ESInstitut Català d'Oncologia · ESHospital Universitari Germans Trias i Pujol · ESBellvitge University Hospital · ESHospital Universitario 12 De Octubre · ESHospital Universitario Virgen de las Nieves · ESInstitut d'Investigació Biomédica de Bellvitge · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe assessed agreement among neurosurgeons on surgical approaches to individual glioblastoma patients and between their approach and those recommended by the topographical staging system described by Shinoda.

methodsFive neurosurgeons were provided with pre-surgical MRIs of 76 patients. They selected the surgical approach [biopsy, partial resection, or gross total resection (GTR)] that they would recommend for each patient. They were blinded to each other's response and they were told that patients were younger than 50 years old and without symptoms. Three neuroradiologists classified each case according to the Shinoda staging system.

resultsBiopsy was recommended in 35.5-82.9%, partial resection in 6.6-32.9%, and GTR in 3.9-31.6% of cases. Agreement among their responses was fair (global kappa = 0.28). Nineteen patients were classified as stage I, 14 as stage II, and 43 as stage III. Agreement between the neurosurgeons and the recommendations of the staging system was poor for stage I (kappa = 0.14) and stage II (kappa = 0.02) and fair for stage III patients (kappa = 0.29). An individual analysis revealed that in contrast to the Shinoda system, neurosurgeons took into account T2/FLAIR sequences and gave greater weight to the involvement of eloquent areas.

conclusionsThe surgical approach to glioblastoma is highly variable. A staging system could be used to examine the impact of extent of resection, monitor post-operative complications, and stratify patients in clinical trials. Our findings suggest that the Shinoda staging system could be improved by including T2/FLAIR sequences and a more adequate weighting of eloquent areas.

Indexed as

AdultBrain NeoplasmsClinical Trials, Phase II as TopicGlioblastomaHumansMaleMiddle AgedNeoplasm StagingNeurosurgeonsNeurosurgical ProceduresRandomized Controlled Trials as TopicSurveys and QuestionnairesGlioblastomaIntentionInter-observer variabilityRadicalityStagingSurgery

Identifiers

PMID28005261
OpenAlexW2567600036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.